Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 2,121,094 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 2,121,094 | n/a |
| Jun 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 53,588 | $169.1K |
| Mar 18, 2026 | Esperion Therapeutics, Inc. (ESPR) | Sale | 25,578 | $69.5K |
| Mar 16, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 723,760 | n/a |
| Dec 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 48,244 | $177.2K |
| Sep 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 28,427 | $79.3K |
| Jun 18, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 30,474 | $33.8K |
| Mar 19, 2025 | Esperion Therapeutics, Inc. (ESPR) | Sale | 13,047 | $19.6K |
| Mar 17, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 840,000 | n/a |
| Dec 18, 2024 | Esperion Therapeutics, Inc. (ESPR) | Sale | 12,447 | $30.7K |